Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for ...

This e-bike from Tern is built with countless proprietary features which shape the one-size-fits-all backbone to its rider - costs over what riders want to pay ...

SLS and TERN are advancing leukemia therapies, with TERN-701 targeting CML and GPS positioned as a Phase 3 maintenance ...

Electric bikes have revolutionized the world of cycling in a way we never thought possible. With electric bicycles of today, some people are actually able to replace their cars on a near-daily basis ...

If consummated, the deal would hand Merck a treatment that could challenge Novartis’ fast-selling Scemblix. But the low ...

Terns Pharmaceuticals (TERN) has drawn fresh interest after recent share price moves, with the stock trading at $52.79 and showing double digit total returns over the past year and past 3 months. See ...

With years of producing high-performing e-bikes, Tern's electric bicycles have established a reputation for excellence. They are not inexpensive in any way, and have always featured among the best ...

Vestal Point Capital recently disclosed a major investment in Terns Pharmaceuticals, acquiring 4,500,000 shares valued at US$181.80 million to back the company’s clinical-stage pipeline in liver, ...

Tern’s electric bicycles have become synonymous with quality, a reputation that has been earned over several years of high-performing e-bikes. They’re not cheap in any sense of the word, which leads ...

Tern recently updated its midtier electric cargo bike, the Tern HSD. I recently had the chance to check out the bike along with Tern’s founder and team captain, Josh Hon, at Eurobike 2023, and here’s ...

Small and compact. Fabulous-looking. 400-pound load maximum. Walk assist. Streamlined handlebar display. Can stand on its end to fit in an elevator. Fold-down handlebars means you can transport it ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.